These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1389 related articles for article (PubMed ID: 9551360)
21. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells. Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156 [TBL] [Abstract][Full Text] [Related]
22. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. Kawakami Y; Zakut R; Topalian SL; Stötter H; Rosenberg SA J Immunol; 1992 Jan; 148(2):638-43. PubMed ID: 1729379 [TBL] [Abstract][Full Text] [Related]
23. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma. Takahashi T; Irie RF; Nishinaka Y; Hoon DS Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820 [TBL] [Abstract][Full Text] [Related]
24. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. Dubey C; Croft M; Swain SL J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426 [TBL] [Abstract][Full Text] [Related]
25. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines. Dessureault S; Gallinger S J Surg Res; 1996 Jul; 64(1):42-8. PubMed ID: 8806472 [TBL] [Abstract][Full Text] [Related]
26. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095 [TBL] [Abstract][Full Text] [Related]
27. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313 [TBL] [Abstract][Full Text] [Related]
28. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040 [TBL] [Abstract][Full Text] [Related]
29. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. van der Bruggen P; Bastin J; Gajewski T; Coulie PG; Boël P; De Smet C; Traversari C; Townsend A; Boon T Eur J Immunol; 1994 Dec; 24(12):3038-43. PubMed ID: 7805731 [TBL] [Abstract][Full Text] [Related]
30. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes. Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947 [TBL] [Abstract][Full Text] [Related]
31. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. Gajewski TF; Renauld JC; Van Pel A; Boon T J Immunol; 1995 Jun; 154(11):5637-48. PubMed ID: 7538528 [TBL] [Abstract][Full Text] [Related]
32. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780 [TBL] [Abstract][Full Text] [Related]
33. Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells. Salazar-Onfray F; Nakazawa T; Chhajlani V; Petersson M; Kärre K; Masucci G; Celis E; Sette A; Southwood S; Appella E; Kiessling R Cancer Res; 1997 Oct; 57(19):4348-55. PubMed ID: 9331097 [TBL] [Abstract][Full Text] [Related]
34. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. Slingluff CL; Cox AL; Henderson RA; Hunt DF; Engelhard VH J Immunol; 1993 Apr; 150(7):2955-63. PubMed ID: 7681084 [TBL] [Abstract][Full Text] [Related]
35. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Latouche JB; Sadelain M Nat Biotechnol; 2000 Apr; 18(4):405-9. PubMed ID: 10748520 [TBL] [Abstract][Full Text] [Related]
36. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation. Wilson JL; Cunningham AC; Kirby JA Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066 [TBL] [Abstract][Full Text] [Related]
37. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo. Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791 [TBL] [Abstract][Full Text] [Related]
39. Apoptosis of a human melanoma cell line specifically induced by membrane-bound single-chain antibodies. de Inés C; Cochlovius B; Schmidt S; Kipriyanov S; Rode HJ; Little M J Immunol; 1999 Oct; 163(7):3948-56. PubMed ID: 10490996 [TBL] [Abstract][Full Text] [Related]
40. Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. Mentzer SJ; Barbosa JA; Strominger JL; Biro PA; Burakoff SJ J Immunol; 1986 Jul; 137(2):408-13. PubMed ID: 3088100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]